Biopsy of Prostate

PROCEDURE10 trials

Conditions

Elevated PSAHealth Status UnknownHormone-Resistant Prostate CancerLocalized Prostate CarcinomaMetastatic Prostatic AdenocarcinomaProstate AdenocarcinomaProstate CancerProstate Carcinoma

Early Phase 1

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

Active, not recruitingNCT05160597

Jonsson Comprehensive Cancer CenterProstate Carcinoma

Start: 2022-01-13End: 2027-01-07Target: 30Updated: 2026-02-12

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

RecruitingNCT05852041

Northwestern UniversityProstate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v8, Stage IIB Prostate Cancer AJCC v8 +1

Start: 2023-06-07End: 2035-06-07Target: 40Updated: 2025-05-22

Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

RecruitingNCT07164027

Jonsson Comprehensive Cancer CenterProstate Carcinoma

Start: 2025-11-14End: 2037-01-28Target: 30Updated: 2026-03-10

Phase 1

Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial

CompletedNCT06661902

University of WashingtonProstate Cancer

Start: 2025-01-09End: 2026-01-27Updated: 2026-02-17

Phase 2

Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel

TerminatedNCT01253642

OHSU Knight Cancer InstituteHormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma, Prostate Adenocarcinoma +1

Start: 2010-07-12End: 2017-09-15Updated: 2019-10-02

Phase 3

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Not yet recruitingNCT06024772

Thomas Jefferson UniversityProstate Carcinoma

Start: 2026-03-15End: 2027-02-28Target: 300Updated: 2025-12-22

Phase 4

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

SuspendedNCT06733350

Roswell Park Cancer InstituteLocalized Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 +1

Start: 2025-01-15End: 2029-01-15Target: 600Updated: 2026-02-09

Unknown Phase

Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

WithdrawnNCT02597894

Jonsson Comprehensive Cancer CenterStage III Prostate Adenocarcinoma

Start: 2018-03-01End: 2020-03-01Updated: 2020-07-24

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Active, not recruitingNCT03234556

University of Southern CaliforniaElevated PSA, Health Status Unknown

Start: 2017-09-25End: 2028-05-23Updated: 2025-12-22

Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy

Not yet recruitingNCT07075705

Roswell Park Cancer InstituteProstate Carcinoma

Start: 2026-04-15End: 2027-01-15Target: 138Updated: 2026-03-11

Related Papers

A Pilot Study of <sup>18</sup> F‐rhPSMA‐7.3‐PET/MRI to Reduce Mischaracterization of Active Surveillance and Focal Therapy Candidates With Occult Higher Risk Disease

The Prostate2026-03-15

Detection of MRI‐Invisible Disease Using PSMA PET/CT in a Patient Considering Focal Therapy

Case Reports in Urology2025-01-011 citations